Support our Foundation of Myology project
1722 news items
An optimised version of gene therapy being studied in SMA
On 23/06/2025
Beijing researchers report the results of preclinical studies on a new-generation gene therapy for SMA: the new transgene (AAV9-coSMN1) contains an optimised codon, carried by…
Clinical presentations of immune-mediated necrotizing myopathy need to be better recognised
On 23/06/2025
American clinicians, including Andrew Mammen, the researcher behind the first descriptions of immune-mediated necrotizing myopathy (IMNM), take stock of this pathology and highlight its atypical…
Satish B. Moparthi, co-winner of the ‘Grandes Avancées Françaises en Biologie’ award from the French Academie des Sciences
On 20/06/2025
Satish Babu Moparthi, a post-doctoral fellow in the ‘Muscle cell organisation and therapy of centronuclear dominant myopathy’ team at the Center of Research in Myology…
Long-term efficacy of nusinersen varies according to the frequency of injection
On 20/06/2025
Japanese researchers have compared two protocols, Japanese and European, for administering nusinersen in the treatment of SMA: for regulatory reasons, the Japanese protocol involves only…
Risdiplam tablets approved at European level
On 19/06/2025
Already available in the oral solution form, which can be stored in the refrigerator or, exceptionally, at room temperature for up to 5 days, risdiplam…
A case of acquired and reversible rod myopathy following leukaemia
On 19/06/2025
Researchers at the Créteil Neuromuscular Disease Reference Centre report the rather exceptional case of a patient who developed myopathic symptoms during an immunological complication (graft-versus-host…
The corner stone of our Foundation of Myology was laid on 17 June
On 17/06/2025
On Tuesday 17 June, we laid the corner stone for our future Foundation of Myology, the first foundation worldwide dedicated to muscle research, in the…
Exploring the infinitely small – Interview with Stéphane Vassilopoulos
On 16/06/2025
An expert in cell biology and molecular biology, Stéphane Vassilopoulos is co-director of the ‘Muscle cell organization and therapy of dominant centronuclear myopathy‘ team at…
Va-C-Nemus reassures on the safety of vaccination against Covid-19 in NMD
On 16/06/2025
Launched in 2021, the Va-C-Nemus national prospective observational study involved 1,020 adults with a neuromuscular disease of genetic or autoimmune origin, 18% of whom were…
M&M’s – Muscle Monday Seminar – 23 June – Eric Allemand (France)
On 16/06/2025
Regulation of transcriptome diversity through alternative splicing in hematological genetic disorders Monday 23 June 2025 – 12h00-13h00 Eric Allemand, PhD (Imagine Institute, Paris, France) More information on the…
Seeing our muscles in action – Interview with Constantin Slioussarenko
On 12/06/2025
Constantin Slioussarenko, an engineer by training, is a researcher in the NMR and Spectroscopy Laboratory, co-directed by Harmen Reyngoud and Benjamin Marty, at the Neuromuscular…
A look back at the 3rd edition of ‘Muscle Week’
On 12/06/2025
The 3ᵉ edition of Muscle Week, organised from 2 to 8 June 2025 by the Institute of Myology and AFM-Téléthon, mobilised researchers, healthcare professionals, the…
Building the Muscle Atlas – Interview with Bruno Cadot
On 11/06/2025
Bruno Cadot is head of research in the ‘Signalling pathways and striated muscles’ team led by Antoine Muchir at the Center of Research in Myology…
The evolution of the new Morimoto-Ruy-Malicdan syndrome described in two brothers
On 10/06/2025
In a previous study published in 2024, Marie Morimoto et al. described nine cases of a new congenital myopathy linked to biallelic variants of the…
Towards a reassessment of certain contraindications to the use of drugs in autoimmune myasthenia gravis
On 03/06/2025
American researchers have investigated the possible complications associated with the use of several classes of antibiotics known to be harmful to myasthenia gravis patients: data…
The association of dermatomyositis and encephalopathy is exceptional but should be noted
On 02/06/2025
Mexican clinicians report the clinical and immunological data of three patients with concomitant encephalopathy and dermatomyositis (DM): the three patients were adults in their fifties…
Rising incidence of motor neurone disease in France before the Covid-19 crisis
On 30/05/2025
Using data from the French National Health Data System (SNDS), a French team has carried out a study of changes in the incidence of motor…
No additional long-term beneficial effects for the bisoprolol-perindopril combination
On 28/05/2025
British clinicians report the long-term results of a prophylactic treatment for cardiomyopathy in Duchenne muscular dystrophy (DMD): the combination of perindopril (a conversion enzyme inhibitor)…
Advances in myasthenia gravis – 2025
On 28/05/2025
This document presents a selection of myasthenia gravis research news stories from the past year (ongoing observational studies and clinical trials, scientific and medical publications…).…
Variable severity of SMA in patients with four copies of the SMN2 gene
On 27/05/2025
A study published using data from the SMA France register, set up in 2020, shows a wide variety of phenotypes in patients with SMN1-related proximal…
